![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Pott, C.; Delfau, M.; Macintyre, E.; Ribrag, V.; Klapper, W.; Unterhalt, M.; Kneba, M.; Hiddemann, W.; Hermine, O.; Kluin-Nelemans, H.; Dreyling, M. und Hoster, E.
(2017):
Implications of deep molecular response after induction and in maintenance treatment in elderly patients with mantle cell lymphoma: updated results of the randomized EU-MCL elderly trial.
In: Oncology Research and Treatment, Bd. 40: S. 13
Tam, C.; Roberts, A.; Anderson, M. A.; Dawson, S. J.; Hicks, R.; Pott, C.; Westerman, D.; Burke, G.; Kamel, S.; Dreyling, M.; Dawson, M. und Seymour, J.
(2016):
The combination of ibrutinib and venetoclax (ABT-199) rapidly achieves complete remissions in patients with relapsed/refractory mantle cell lymphoma: Preliminary results of the phase II AIM study.
In: Haematologica, Bd. 101: S. 103
Pott, C.; Belada, D.; Danesi, N.; Fingerle-Rowson, G.; Gribben, J.; Harbron, C.; Hoster, E.; Kahl, B.; Mundt, K.; Sebban, C.; Sehn, L. H. und Cheson, B. D.
(2016):
lokale Zellexpression und Infl ammation.
In: British Journal of Haematology, Bd. 173: S. 93-94
Ladetto, M.; Buske, C.; Hutchings, M.; Dreyling, M.; Gaidano, G.; Le Gouill, S.; Luminari, S.; Pott, C.; Zamò, A. und Zucca, E.
(2016):
ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia.
In: Annals of Oncology, Bd. 27, Nr. 12: S. 2149-2160
Herzog, A.; Knecht, H.; Herrmann, D.; Unterhalt, M.; Hiddemann, W.; Kneba, M.; Brueggemann, M.; Hoster, E. und Pott, C.
(2016):
IgH-based Next -Generation Sequencing for MRD detection in follicular lymphoma.
In: Oncology Research and Treatment, Bd. 39: S. 120